BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19663115)

  • 1. Tamoxifen-induced ultraviolet, recall dermatitis.
    Ledet JJ; Grafton LH
    J Drugs Dermatol; 2009 Aug; 8(8):761-2. PubMed ID: 19663115
    [No Abstract]   [Full Text] [Related]  

  • 2. Tamoxifen-induced radiation recall dermatitis.
    Kundranda MN; Daw HA
    Am J Clin Oncol; 2006 Dec; 29(6):637-8. PubMed ID: 17149005
    [No Abstract]   [Full Text] [Related]  

  • 3. Tamoxifen induced radiation recall dermatitis in a breast cancer patient.
    Barco I; Fraile M; Vidal M; Cambra MJ; Vallejo E; Deu J; González S; Giménez N; Pessarrodona A; García-Fernández A
    Breast J; 2018 Jul; 24(4):662-663. PubMed ID: 29517150
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormonal treatment duration in elderly patients: an open question.
    Crivellari D; Goldhirsch A; Coates A
    J Clin Oncol; 2004 Mar; 22(6):1164-5; author reply 1165. PubMed ID: 15020626
    [No Abstract]   [Full Text] [Related]  

  • 5. Tamoxifen-induced radiation recall dermatitis.
    Bourgeois A; Grisoli SB; Soine EJ; Rosen LB
    Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen-induced radiation recall dermatitis: three calls from Egypt.
    Salah E
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e386-e388. PubMed ID: 28231379
    [No Abstract]   [Full Text] [Related]  

  • 7. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
    McCaul KA
    Obstet Gynecol; 2005 Jan; 105(1):217-8; author reply 218-9. PubMed ID: 15625169
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 9. High-grade endometrial stromal sarcoma following tamoxifen treatment.
    Engin H
    Gynecol Oncol; 2008 Jan; 108(1):253-4. PubMed ID: 17928038
    [No Abstract]   [Full Text] [Related]  

  • 10. [Radiotherapy-induced pemphigus].
    Correia MP; Santos D; Jorge M; Coutinho S
    Acta Med Port; 1998 Jun; 11(6):581-3. PubMed ID: 9773540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen.
    Nurs Times; 2006 Feb 21-27; 102(8):33. PubMed ID: 16519033
    [No Abstract]   [Full Text] [Related]  

  • 12. Tamoxifen and pregnancy.
    Barthelmes L; Gateley CA
    Breast; 2004 Dec; 13(6):446-51. PubMed ID: 15563850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptance of tamoxifen chemoprevention by physicians and women at risk.
    McKay A; Latosinsky S; Martin W
    Cancer; 2005 Jan; 103(1):209-10. PubMed ID: 15540238
    [No Abstract]   [Full Text] [Related]  

  • 14. Tamoxifen-induced radiation recall dermatitis.
    Singer EA; Warren RD; Pennanen MF; Collins BT; Hayes DF
    Breast J; 2004; 10(2):170-1. PubMed ID: 15009054
    [No Abstract]   [Full Text] [Related]  

  • 15. What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy.
    Koc M
    J Clin Oncol; 2007 Dec; 25(36):5841; author reply 5844-5. PubMed ID: 18089889
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen-induced fatty liver in patients with breast cancer.
    Ogawa Y; Murata Y; Nishioka A; Inomata T; Yoshida S
    Lancet; 1998 Mar; 351(9104):725. PubMed ID: 9504521
    [No Abstract]   [Full Text] [Related]  

  • 17. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.
    Jordan VC
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiation-induced side effects with or without systemic therapies: prime time for prediction of individual radiosensitivity.
    Azria D; Rosenstein BS; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1293-4. PubMed ID: 18640495
    [No Abstract]   [Full Text] [Related]  

  • 19. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
    Fabian C
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909
    [No Abstract]   [Full Text] [Related]  

  • 20. The changing perspective on breast cancer and chemotherapy. Three new developments are better able to predict breast cancer recurrence and chemotherapy effectiveness.
    Health News; 2006 Aug; 12(8):14-5. PubMed ID: 16913035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.